In Silico Vaccine Design Based on Molecular Simulations of Rhinovirus Chimeras Presenting HIV-1 gp41 Epitopes

被引:32
|
作者
Lapelosa, Mauro [1 ,2 ,3 ]
Gallicchio, Emilio [1 ,2 ]
Arnold, Gail Ferstandig [2 ,3 ]
Arnold, Eddy [2 ,3 ]
Levy, Ronald M. [1 ,2 ]
机构
[1] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA
[3] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
基金
美国国家卫生研究院;
关键词
vaccine design; monoclonal antibody 2F5; replica exchange method; chimeric virus; VIRUS TYPE-1 ENVELOPE; PROXIMAL EXTERNAL REGION; IMPLICIT SOLVENT MODEL; COMMON COLD VIRUS; ANTIBODY; 2F5; NEUTRALIZING ANTIBODIES; FORCE-FIELD; GLYCOPROTEIN; PEPTIDE; LOOP;
D O I
10.1016/j.jmb.2008.10.089
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A cluster of promising epitopes for the development of human immunodeficiency virus (HIV) vaccines is located in the membrane-proximal external region (MPER) of the gp41 subunit of the HIV envelope spike structure. The crystal structure of the peptide corresponding to the so-called ELDKWA epitope (HIV-1 HxB2 gp41 residues 662-668), in complex with the corresponding broadly neutralizing human monoclonal antibody 2F5, provides a target for structure-based vaccine design strategies aimed at finding macromolecular carriers that are able to present this MPER-derived epitope with optimal antigenic activity. To this end, a series of replica exchange molecular dynamics computer simulations was conducted to characterize the distributions of conformations of ELDKWA-based epitopes inserted into a rhinovirus carrier and to identify those with the highest fraction of conformations that are able to bind 2F5. The length, hydrophobic character, and precise site of insertion were found to be critical for achieving structural similarity to the target crystal structure. A construct with a high degree of complementarity to the corresponding determinant region of 2175 was obtained. This construct was employed to build a high-resolution structural model of the complex between the 2175 antibody and the chimeric human rhinovirus type 14:HIV-1 ELDKWA virus particle. Additional simulations, which were conducted to study the conformational propensities of the ELDKWA region in solution, confirm the hypothesis that the ELDKWA region of gp41 is highly flexible and capable of assuming helical conformations (as in the postfusion helical bundle structure) and beta-turn conformations (as in the complex with the 2F5 antibody). These results also suggest that the ELDKWA epitope can be involved in intramolecular-and likely intermolecular-hydrophobic interactions. This tendency offers an explanation for the observation that mutations decreasing the hydrophobic character of the MPER in many cases result in conformational changes that increase the affinity of this region for the 2175 antibody. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:675 / 691
页数:17
相关论文
共 50 条
  • [1] Antigenic Characteristics of Rhinovirus Chimeras Designed in silico for En5hanced Presentation of HIV-1 gp41 Epitopes
    Lapelosa, Mauro
    Arnold, Gail Ferstandig
    Gallicchio, Emilio
    Arnold, Eddy
    Levy, Ronald M.
    JOURNAL OF MOLECULAR BIOLOGY, 2010, 397 (03) : 752 - 766
  • [2] Structure-Based Design of a Protein Immunogen that Displays an HIV-1 gp41 Neutralizing Epitope
    Stanfield, Robyn L.
    Julien, Jean-Philippe
    Pejchal, Robert
    Gach, Johannes S.
    Zwick, Michael B.
    Wilson, Ian A.
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 414 (03) : 460 - 476
  • [3] Characterization of a trimeric MPER containing HIV-1 gp41 antigen
    Hinz, Andreas
    Schoehn, Guy
    Quendler, Heribert
    Hulsik, David Lutje
    Stiegler, Gabi
    Katinger, Hermann
    Seaman, Michael S.
    Montefiori, David
    Weissenhorn, Winfried
    VIROLOGY, 2009, 390 (02) : 221 - 227
  • [4] Analysis of gp41 epitopes in model viral membranes to study HIV-1 neutralization
    Reichart, T.
    Baksh, M.
    Zwick, M.
    Finn, M.
    Dawson, P.
    RETROVIROLOGY, 2012, 9
  • [5] Analysis of gp41 epitopes in model viral membranes to study HIV-1 neutralization
    T Reichart
    M Baksh
    M Zwick
    M Finn
    P Dawson
    Retrovirology, 9
  • [6] Neutralizing Antibodies Targeting HIV-1 gp41
    Caillat, Christophe
    Guilligay, Delphine
    Sulbaran, Guidenn
    Weissenhorn, Winfried
    VIRUSES-BASEL, 2020, 12 (11):
  • [7] Small Molecule Mimetics of an HIV-1 gp41 Fusion Intermediate as Vaccine Leads
    Caulfield, Michael J.
    Dudkin, Vadim Y.
    Ottinger, Elizabeth A.
    Getty, Krista L.
    Zuck, Paul D.
    Kaufhold, Robin M.
    Hepler, Robert W.
    McGaughey, Georgia B.
    Citron, Michael
    Hrin, Renee C.
    Wang, Ying-Jie
    Miller, Michael D.
    Joyce, Joseph G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (52) : 40604 - 40611
  • [8] The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring
    Zwick, MB
    AIDS, 2005, 19 (16) : 1725 - 1737
  • [9] HIV-1 gp41 Fusion Intermediate: A Target for HIV Therapeutics
    Pan, Chungen
    Liu, Shuwen
    Jiang, Shibo
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (02) : 94 - 105
  • [10] Development of HIV-1 Fusion Inhibitors Targeting gp41
    Lu, K.
    Asyifah, M. R.
    Shao, F.
    Zhang, D.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (17) : 1976 - 1996